Cargando…

Immunostimulation and Immunoinhibition of Premalignant Lesions

BACKGROUND: The immune reaction may be either stimulatory or inhibitory to tumor growth, depending upon the local ratio of immune reactants to tumor cells. HYPOTHESIS: A tumor-stimulatory immune response may be essential for survival of a neoplasm in vivo and for the biological progression from a pr...

Descripción completa

Detalles Bibliográficos
Autor principal: Prehn, Richmond T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797005/
https://www.ncbi.nlm.nih.gov/pubmed/17280618
http://dx.doi.org/10.1186/1742-4682-4-6
_version_ 1782132279098736640
author Prehn, Richmond T
author_facet Prehn, Richmond T
author_sort Prehn, Richmond T
collection PubMed
description BACKGROUND: The immune reaction may be either stimulatory or inhibitory to tumor growth, depending upon the local ratio of immune reactants to tumor cells. HYPOTHESIS: A tumor-stimulatory immune response may be essential for survival of a neoplasm in vivo and for the biological progression from a premalignant lesion to a malignancy. Neither a positive nor a negative correlation between the magnitude of an immune-cell infiltrate and a cancer's prognosis can reveal whether the infiltrate was stimulating or inhibiting to the tumor's growth unless the position on the nonlinear curve that relates tumor growth to the magnitude of the immune reaction is known. DISCUSSION: This hypothesis is discussed in relation to the development of human malignant melanomas and colorectal cancers.
format Text
id pubmed-1797005
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17970052007-02-13 Immunostimulation and Immunoinhibition of Premalignant Lesions Prehn, Richmond T Theor Biol Med Model Review BACKGROUND: The immune reaction may be either stimulatory or inhibitory to tumor growth, depending upon the local ratio of immune reactants to tumor cells. HYPOTHESIS: A tumor-stimulatory immune response may be essential for survival of a neoplasm in vivo and for the biological progression from a premalignant lesion to a malignancy. Neither a positive nor a negative correlation between the magnitude of an immune-cell infiltrate and a cancer's prognosis can reveal whether the infiltrate was stimulating or inhibiting to the tumor's growth unless the position on the nonlinear curve that relates tumor growth to the magnitude of the immune reaction is known. DISCUSSION: This hypothesis is discussed in relation to the development of human malignant melanomas and colorectal cancers. BioMed Central 2007-02-06 /pmc/articles/PMC1797005/ /pubmed/17280618 http://dx.doi.org/10.1186/1742-4682-4-6 Text en Copyright © 2007 Prehn; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Prehn, Richmond T
Immunostimulation and Immunoinhibition of Premalignant Lesions
title Immunostimulation and Immunoinhibition of Premalignant Lesions
title_full Immunostimulation and Immunoinhibition of Premalignant Lesions
title_fullStr Immunostimulation and Immunoinhibition of Premalignant Lesions
title_full_unstemmed Immunostimulation and Immunoinhibition of Premalignant Lesions
title_short Immunostimulation and Immunoinhibition of Premalignant Lesions
title_sort immunostimulation and immunoinhibition of premalignant lesions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797005/
https://www.ncbi.nlm.nih.gov/pubmed/17280618
http://dx.doi.org/10.1186/1742-4682-4-6
work_keys_str_mv AT prehnrichmondt immunostimulationandimmunoinhibitionofpremalignantlesions